# Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

> **NCT07526454** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Electroconvulsive Therapy
- Intravenous Ketamine
- Treatment-Resistant
- Major Depressive Disorder

## Interventions

- **DRUG:** Electroconvulsive Therapy
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT07526454
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07526454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07526454, "Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07526454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*